Spironolactone and intermenstrual bleeding in polycystic ovary syndrome with normal BMI-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Spironolactone and intermenstrual bleeding in polycystic ovary syndrome with normal BMI

Published:2016-04-12 Issue:9 Volume:39 Page:1015-1021
ISSN:1720-8386
Container-title:Journal of Endocrinological Investigation
language:en
Short-container-title:J Endocrinol Invest

Author:

Sabbadin C.,Andrisani A.,Zermiani M.,Donà G.,Bordin L.,Ragazzi E.,Boscaro M.,Ambrosini G.,Armanini D.

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

http://link.springer.com/content/pdf/10.1007/s40618-016-0466-0.pdf

Reference21 articles.

1. Armanini D, Karbowiak I, Goi A, Mantero F, Funder JW (1985) In-vivo metabolites of spironolactone and potassium canrenoate: determination of potential anti-androgenic activity by a mouse kidney cytosol receptor assay. Clin Endocrinol 23:341–347

2. Shapiro G, Evron S (1980) A novel use of spironolactone: treatment of hirsutism. J Clin Endocrinol Metabol 51:429–432

3. Sirmans SM, Pate KA (2013) Epidemiology, diagnosis, and management of polycystic ovary syndrome. Clin Epidemiol 6:1–13

4. Spritzer PM, Lisboa KO, Mattiello S, Lhullier F (2000) Spironolactone as a single agent for long-term therapy of hirsute patients. Clin Endocrinol 52:587–594

5. Corvol P, Michaud A, Menard J, Freifeld M, Mahoudeau J (1975) Antiandrogenic effect of spironolactones: mechanism of action. Endocrinology 97:52–58

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessing medication use patterns among patients with polycystic ovary syndrome at a tertiary care teaching hospital in South Korea: A retrospective study;Medicine;2024-08-09

2. Long-Lasting Effects of Spironolactone after its Withdrawal in Patients with Hyperandrogenic Skin Disorders;Endocrine, Metabolic & Immune Disorders - Drug Targets;2023-02

3. Feminizing gender‐affirming hormone therapy for the transgender and gender diverse population: An overview of treatment modality, monitoring, and risks;Neurourology and Urodynamics;2022-11-20

4. Low-dose spironolactone ameliorates adipose tissue inflammation and apoptosis in letrozole-induced PCOS rat model;BMC Endocrine Disorders;2022-09-07

5. Controversies in the Pathogenesis, Diagnosis and Treatment of PCOS: Focus on Insulin Resistance, Inflammation, and Hyperandrogenism;International Journal of Molecular Sciences;2022-04-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3